Company Announcements

Tatneft Obtained Permit to Continue ADR Program

Source: RNS
RNS Number : 7772L
PJSC Tatneft
17 May 2022

17 May 2022

Tatneft obtained a permission to continue the ADR program

Pursuant to part 9 of Article 6 of the Russian Federal Law No. 114-FZ of 16 April 2022 "On amendments to the Federal Law "On Joint Stock Companies" and certain other legislative acts of the Russian Federation" PJSC Tatneft (the "Company") obtained the permission from the Government Commission on Monitoring Foreign Investment in the Russian Federation to continue the circulation of its American depositary receipts (ADRs), ISIN US8766292051, outside of Russia. Therefore, the Company is not required to terminate the related ADRs program pursuant to the deposit agreement between the Company, Citibank N.A. as Depositary and owners and beneficial owners of the ADRs. The rights and obligations of the ADR holders remain subject to requirements of applicable laws.


This press release contains inside information.

Forward-looking statements: This press-release contains certain statements about future events and expectations that are forward-looking in nature. Any statement in this press-release that is not a statement of historical fact is a forward-looking statement that involves known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to differ. PJSC Tatneft assumes no obligations to update the forward-looking statements contained herein to reflect actual results, changes in assumptions or changes in factors affecting these statements.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.